LINC00519 and squamous cell lung carcinoma: LINC00519 was overexpressed and related to a poor prognosis in lung squamous cell carcinoma (LUSC) patients, which promoted tumor progression via miR-450b-5p/miR-515-5p/YAP1 pathway (Ye et al., 2020).